Media Update, page-1248

I didn't say "embarrassing".

You were questioning the professionalism of Pantonic Health based off their website, and I merely pointed out that its not a good look that a small opportunistic company was able to beat Atomo to the punch on both professional and self-administered RATs.
Plus, they were able to secure government contracts, and the CareStart-branded tests are plastered over the media.

IMO, timing and first-mover advantage is a pretty big deal. e.g. supermarkets selling self-tests from next week? Going by Atomo's track record, they wouldn't have secured this contract either even if they did get all the approvals in early... but considering they aren't even on the approved list yet, we can definitely rule them out as a current contender.

Yes, antigen is one part of AT1's business... but the financials says it's also the biggest part currently.. and it's not even something they're manufacturing, but rebranding and reselling.
Ab side is dead, who knows how long it'll take for their other patents to come to market and get approved, HIV market growing but very small, FebriDx surely to come but LDX SP isn't looking particularly healthy.

AT1 may have a more diversified income stream, but the initial hype for the company was its potential to capitalise on the Covid movement. Long-term, I'm sure it'll do fine. In the short-term, either lots of missed opportunities or they haven't divulged any big contracts publicly yet (which would be equally as annoying).